ADVERTISEMENT

13. ANTIMICROBIAL RESISTANCE

These free D.Pharm (Diploma in Pharmacy) notes on antimicrobial resistance in pharmacotherapeutics are part of Pharmacotherapeutics, Part II (2nd year). Below is a short summary of what the notes cover. For the full explanation, read the complete PDF notes embedded at the end of the page. You can browse every topic in the Pharmacotherapeutics category.

Overview of antimicrobial resistance in pharmacotherapeutics

These notes explain anti-microbial resistance (AMR), why microbes become superbugs, and the main causes. They cover the types of resistance (MDR, XDR and PDR), the four resistance mechanisms, and the general methods used to prevent and control AMR, including multidrug-resistant organisms such as MRSA and VRE.

ADVERTISEMENT

Anti-Microbial Resistance (Amr)

Anti-microbial resistance (AMR) means a change in the behaviour of microorganisms (bacteria, fungi, viruses and parasites) after they are exposed to anti-microbial drugs. These drugs include antibiotics, anti-fungals, anti-virals, anti-malarials and anthelmintics.

Topics covered: Causes of AMR; Types of AMR; Mechanism of Anti-microbial Resistance; Prevention of MDRO (Multidrug-Resistant Organisms); Infection; Risk Factors.

Key points on antimicrobial resistance in pharmacotherapeutics

  • Anti-microbial resistance is a change in the behaviour of microorganisms after exposure to anti-microbial drugs, and such organisms are often called superbugs.
  • Multidrug resistance means resistance to more than one anti-microbial agent, while pandrug resistance means resistance to all approved anti-microbial agents.
  • Self-medication, over-the-counter availability of medicines, poor compliance with dose instructions and inadequate infection control programs are listed as important causes of AMR.
  • Microbes develop resistance by limiting drug uptake, modifying the drug target, inactivating the drug, or actively pumping the drug out through efflux pumps.
  • Common multidrug-resistant organisms include MRSA, VRE, ESBL-producing bacteria and penicillin-resistant Streptococcus pneumoniae, which are prevented mainly by hand washing and infection control measures.

Frequently asked questions on antimicrobial resistance in pharmacotherapeutics

What is anti-microbial resistance?

Anti-microbial resistance is a change in the behaviour of bacteria, fungi, viruses and parasites after exposure to drugs, so the medicines no longer work and the infection persists and spreads.

What is the difference between MDR, XDR and PDR?

MDR is resistance to more than one anti-microbial agent. XDR is resistance to multiple agents and almost all approved ones. PDR is resistance to all approved anti-microbial agents.

How can anti-microbial resistance be prevented?

Prevention includes anti-microbial stewardship programs, education and awareness, infection prevention and control such as hand hygiene, higher immunization rates, and regulation of anti-microbial use in agriculture and animal husbandry.

ADVERTISEMENT

Download the Full PDF Notes: Antimicrobial Resistance

This page gives a brief description of what the PDF covers. For more information, read the full embedded PDF notes below.

ADVERTISEMENT

This page is part of the Pharmacotherapeutics series for D.Pharm students (Diploma in Pharmacy, not Pharm.D) on DPHARM GURU. Bookmark this page and share it with classmates who are preparing for the same exam.

Related notes: 1. PHARMACOTHERAPEUTICS: INTRODUCTION, SCOPE AND OBJECTIVES, 1. RATIONAL USE OF MEDICINES, EVIDENCE-BASED MEDICINE, ESSENTIAL MEDICINES LIST AND STANDARD TREATMENT GUIDELINES.

Next: 14. WOMEN’S HEALTH. Back to the Pharmacotherapeutics category.

Share your love

Leave a Reply

Your email address will not be published. Required fields are marked *